DermTech Inc (NAS:DMTK)
$ 0.638 0.018 (2.9%) Market Cap: 22.31 Mil Enterprise Value: 20.21 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 44/100

Q4 2020 DermTech Inc Earnings Call Transcript

Mar 04, 2021 / 09:30PM GMT
Release Date Price: $52.98 (-17.18%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to DermTech's Fourth Quarter 2020 Financial Results Conference Call.

(Operator Instructions) It is now my pleasure to turn the conference over to Ms. Caroline Corner. Ma'am, please go ahead.

Caroline Corner

Thank you, operator. Welcome to DermTech's Fourth Quarter and Full Year 2020 Earnings Call. Joining me on today's call are Dr. John Dobak, President and Chief Executive Officer; and Kevin Sun, Chief Financial Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact are considered forward-looking statements.

Forward-looking statements made during this call, including projections of future performance, are based on management's expectations as of today, March 4, 2021, and are subject to various factors, assumptions, risks and uncertainties, which change over time. Actual results could differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot